E sophageal adenocarcinoma is a common malignancy aff ecting more than 16,000 patients in 2010 (1). We report a rare case of esophageal adenocarcinoma with vascular invasion and tumor thrombus extending from the esophageal mass into the azygos vein, as shown on positron emission tomography-computed tomography (PET-CT), which to our knowledge has not been previously reported.
sophageal adenocarcinoma is a common malignancy aff ecting more than 16,000 patients in 2010 (1) . We report a rare case of esophageal adenocarcinoma with vascular invasion and tumor thrombus extending from the esophageal mass into the azygos vein, as shown on positron emission tomography-computed tomography (PET-CT), which to our knowledge has not been previously reported.
CASE REPORT
A 66-year-old man with a several-month history of dysphagia and weight loss presented to a gastroenterologist and underwent upper endoscopy and biopsy. Th is revealed a moderately diff erentiated invasive adenocarcinoma in the distal third of the esophagus. He was then referred for PET-CT, which was performed 60 minutes after the injection of 540.2 MBq F-18 fl ourodeoxyglucose (FDG).
PET-CT images demonstrated a hypermetabolic soft tissue mass in the distal third of the esophagus with a maximum standardized uptake value of 16.1, compatible with a known primary malignancy. A linear focus of hypermetabolism was seen coursing posterior and to the right of the esophageal mass and anterior to a thoracic vertebral body (Figure 1 ). Th is is consistent with tumor thrombus extending into the proximal azygos vein.
A hypermetabolic focus was also present in the right atrium. Th ere was no hypermetabolism in the interposed cardiac wall to suggest direct invasion from the large esophageal mass (Figure 2 ). Findings represented tumor thrombus extension into the right atrium from the extensive tumor thrombus in the azygos system.
Th is examination also showed local and distant metastatic disease, including pulmonary metastasis and pulmonary tumor emboli. Discrete hypermetabolic nodules were seen in the right lower lobe as well as the lingula (Figure 3) . Th e lingular hypermetabolic nodule had a well-rounded confi guration, more compatible with a metastatic pulmonary nodule (2) . Th e right lower lobe lesion was centrally located and corresponded to a segmental lower lobe pulmonary artery, compatible with a metastatic pulmonary embolus from the tumor thrombus that was shown in the right atrium (3).
DISCUSSION
Many articles have been published discussing tumor thrombus. However, despite an estimated 16,640 new cases of esophageal carcinoma diagnosed in 2010, with approximately 14,500 deaths (1), no cases of esophageal adenocarcinoma with vascular invasion and tumor thrombus have been previously reported.
Previously, squamous cell carcinoma was the most common cancer cell type to aff ect the esophagus in the United States. Recently, these statistics have changed, and adenocarcinoma is responsible for over 50% of esophageal cancers (1) . Th e development of adenocarcinoma is due to squamous metaplasia from Barrett esophagus and development of glandular cells in the distal esophagus, which normally line the adjacent stomach (1). Early detection of esophageal adenocarcinoma with subsequent esophagectomy can be curative in many early stage presentations, but most patients present with locally advanced disease (4). Up to 20% to 30% of patients present with distant metastasis (5), as seen in our case, which had both local invasion and pulmonary metastatic disease. Th e most common sites of visceral metastatic disease from esophageal carcinoma are the lungs, liver, bones, and adrenal glands (6) .
Th e PET-CT images shown in this case were obtained in standard fashion, including both multiplanar reformatted PET images and low-dose nonintravenous contrast-enhanced CT localization images from just below the skull vertex through the midthighs. Th e addition of CT images to the PET images allows for more accurate localization of metabolically active fi ndings, with minimal added radiation to the patient. PET-CT has known utility in patients with esophageal carcinoma, both for initial staging and for assessment of treatment response (6) .
Th e diagnosis of vascular thrombus can be made by multiple diff erent imaging modalities. A unique feature of PET-CT demonstrated in this case is the ability to allow the reader to discern metabolically active lesions from nonmetabolically active ones, such as tumor thrombus versus bland thrombus.
Th is feature is a direct refl ection of the tumor thrombus's F-18 FDG avidity (7) . Th e ability to distinguish bland thrombus from tumor thrombus can be important in determining subsequent treatment planning, as the treatment regimens for the two diagnoses vary greatly.
In summary, PET-CT continues to prove useful clinically in the staging and subsequent treatment response of many malignancies. We present a unique case of a staging PET-CT that showed an unsuspected metastatic pattern involving gross vascular invasion from esophageal carcinoma. Figure 3 . Transaxial localization CT, PET, and fusion images through the lower chest show a large rounded hypermetabolic focus just anterior to a lower thoracic vertebral body. This is the patient's known primary esophageal adenocarcinoma. Just anterior to the primary malignancy is another smaller rounded focus of tracer hypermetabolism, which is within the right atrium. This is compatible with tumor extension from the azygos system into the right atrium, as there is no FDG hypermetabolism in the interposed soft tissue to suggest direct invasion. Figure 2 . Transaxial localization CT, PET, and fusion images through the midchest demonstrate a hypermetabolic tumor just anterior to a midthoracic vertebral body. This corresponds to the location of the azygos vein. There are also two distinct foci in the lungs. The right-sided focus corresponds to a right lower lobe segmental pulmonary artery on localization image, compatible with a pulmonary tumor embolus. The hypermetabolic pulmonary nodule in the left upper lobe is subpleural in location and compatible with a metastatic pulmonary nodule.
Dear Dr. Roberts:
I loved your section of the July 2011 issue of Baylor Proceedings. Th e information from the Barron's article was great. I was ship physician on Sea Cloud 10 times (see www.seacloud.com). I am a retired pediatric surgeon.
-Dick G. Ellis, MD Fort Worth, Texas Dear Dr. Roberts: As usual, I thoroughly enjoyed the July Baylor University Medical Center Proceedings. Over my last 17 years in practice, I continue to benefi t from its signifi cance and the information that it has with each publication.
In reviewing the journal, I noticed there is no plastic surgeon on the editorial board. Despite our small fi eld, plastic surgery crosses over numerous disciplines such as craniofacial surgery, hand surgery, surgery of the head and neck, breast surgery, orthopedic surgery, and dermatology. In keeping with this need, I want to recommend William Carpenter, MD. Bill has been on the Baylor campus for approximately 20 years. He is well regarded in many aspects of plastic surgery and is well respected in the community. Additionally, I feel that he has a discerning academic perspective and I think that he would be an outstanding asset to your editorial board.
Reader comments
Once again, I congratulate you on the continued success of the journal.
- Dear Dr. Roberts: I read your Facts and ideas article in the July Proceedings and enjoyed it very much, particularly the discussion of trees, cholesterol, cesarean sections, and life expectancy. Th ere was a typo in "Marathon Run." Th e time is 4:69 minutes per mile, not miles per minute. I was also running 4:42-minute miles in high school, but that was 63 years ago. For whatever it is worth, I completed the Boston Marathon at age 45, running 7-minute miles. Keep up the good work! -C. A. Rundell Jr. Addison, Texas
